Do inflammatory cytokines stimulate the HPA axis and does elevated hs-CRP indicate inflammation that activates the stress axis?

The claim that inflammatory cytokines stimulate the HPA axis to increase cortisol output, and that elevated high-sensitivity C-reactive protein (hs-CRP) reflects systemic inflammation contributing to stress-axis activation, is robustly supported by clinical and mechanistic evidence.

Mechanistic evidence

The interaction between the immune system and the stress axis occurs through a highly coordinated bidirectional loop:

• Signaling Pathways: Proinflammatory cytokines—specifically interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)—signal the brain through three primary routes:
  • Humoral: Diffusion across the blood-brain barrier and entry via circumventricular organs.
  • Neural: Activation of the vagus nerve, which transmits signals to the nucleus tractus solitarius (NTS) and then to the hypothalamus.
  • Endothelial: Cytokines act on brain endothelial cells to produce prostaglandin E2 (PGE2), a critical intermediate that binds to receptors in the hypothalamus to trigger stress responses.
• HPA Activation: These signals converge on the paraventricular nucleus (PVN) of the hypothalamus, stimulating the release of corticotropin-releasing hormone (CRH). This triggers the pituitary gland to release ACTH, which signals the adrenal glands to produce cortisol.
• CRP Regulation: hs-CRP is an acute-phase reactant synthesized in the liver, primarily in response to IL-6. Therefore, elevated hs-CRP serves as a reliable surrogate for the same inflammatory milieu that activates the HPA axis.

Clinical evidence

• Experimental Challenges: In human studies using lipopolysaccharide (LPS) to induce a controlled inflammatory response, a predictable sequence occurs: cytokine levels rise, followed by an ACTH peak within 60–120 minutes, and a robust cortisol increase within 60–180 minutes.
• Chronic Inflammation: Persistent elevation of cytokines and hs-CRP is associated with HPA axis dysregulation. In conditions of chronic low-grade inflammation, the body may develop glucocorticoid resistance, where immune cells become less sensitive to cortisol's anti-inflammatory effects, allowing high inflammation and high cortisol to coexist.
• Predictive Value: A lower "cortisol-to-CRP ratio" has been used in research as an indicator of an inadequate HPA axis response to systemic inflammation, highlighting that the balance between these two systems is critical for health.

Safety and considerations

• Negative Feedback: Under normal physiological conditions, the cortisol released in response to cytokines serves as a "brake" on the immune system, suppressing further cytokine production to prevent runaway inflammation.
• Clinical Relevance: For a 36-year-old female, chronic HPA activation driven by systemic inflammation (indicated by elevated hs-CRP) may contribute to fatigue, mood disturbances, and metabolic shifts, as the HPA axis is diverted from its normal circadian rhythm to respond to inflammatory "stress."

Bottom line

Inflammatory cytokines act as potent biological stressors that stimulate the HPA axis to increase cortisol. Elevated hs-CRP is a validated marker of the systemic inflammatory state that drives this HPA activation, reflecting a complex crosstalk between the immune and endocrine systems.